您的位置: 首页 > 农业专利 > 详情页

ERBB/BTK INHIBITORS
专利权人:
Dizal (Jiangsu) Pharmaceutical Co.; Ltd.
发明人:
Zhengtao LI,Hao ZOU,Wei ZHU,Changmao SHEN,Rumin WANG,Wengeng LIU,Xiang CHEN,Honchung TSUI,Zhenfan YANG,Xiaolin ZHANG
申请号:
US16910208
公开号:
US20200316079A1
申请日:
2020.06.24
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed are compounds inhibiting ErbBs (e.g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat ErbBs (especially mutant forms of ErbBs) or BTK associated diseases, including cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充